↓ Skip to main content

Rationale and design of a randomized controlled trial of the effect of retinol and vitamin D supplementation on treatment in active pulmonary tuberculosis patients with diabetes

Overview of attention for article published in BMC Infectious Diseases, February 2013
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
174 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rationale and design of a randomized controlled trial of the effect of retinol and vitamin D supplementation on treatment in active pulmonary tuberculosis patients with diabetes
Published in
BMC Infectious Diseases, February 2013
DOI 10.1186/1471-2334-13-104
Pubmed ID
Authors

Qiuzhen Wang, Aiguo Ma, Ib Christian Bygbjerg, Xiuxia Han, Yufeng Liu, Shanliang Zhao, Jing Cai

Abstract

The association between pulmonary tuberculosis (PTB) and diabetes mellitus (DM) has been previously attracted much attention. Diabetes alters immunity to tuberculosis, leading to more frequent treatment failure in TB patients with DM. Moreover, TB and DM often coincide with micronutrients deficiencies, such as retinol and vitamin D, which are especially important to immunity of the body and may influence pancreas β-cell function. However, the effects of retinol and vitamin D supplementation in active TB patients with diabetes on treatment outcomes, immune and nutrition state are still uncertain. We are conducting a randomized controlled trial of vitamin A and/or D in active PTB patients with DM in a network of 4 TB treatment clinics to determine whether the supplementation could improve the outcome in the patients.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 174 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 <1%
Germany 1 <1%
South Africa 1 <1%
India 1 <1%
United Kingdom 1 <1%
New Zealand 1 <1%
Denmark 1 <1%
Unknown 167 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 36 21%
Student > Bachelor 22 13%
Researcher 14 8%
Lecturer 12 7%
Student > Postgraduate 10 6%
Other 36 21%
Unknown 44 25%
Readers by discipline Count As %
Medicine and Dentistry 64 37%
Nursing and Health Professions 16 9%
Agricultural and Biological Sciences 10 6%
Pharmacology, Toxicology and Pharmaceutical Science 6 3%
Biochemistry, Genetics and Molecular Biology 5 3%
Other 23 13%
Unknown 50 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2013.
All research outputs
#17,681,263
of 22,699,621 outputs
Outputs from BMC Infectious Diseases
#5,068
of 7,644 outputs
Outputs of similar age
#140,500
of 192,953 outputs
Outputs of similar age from BMC Infectious Diseases
#109
of 163 outputs
Altmetric has tracked 22,699,621 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,644 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,953 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 163 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.